Indeed, IL-6 was also reported to inhibit Treg cell differentiation induced by TGF-β (46) Our results showing increased IL-6 serum levels in TET-AD patients compared to TET patients, support the role of this cytokine in sustaining AD and contributing to Treg cell decrease. The gene discussed is IL6; the disease is Alzheimer disease.